Your browser doesn't support javascript.
loading
The immune response to a fungus in pancreatic cancer samples.
Brayer, K J; Hanson, J A; Cingam, S; Martinez, C; Ness, S A; Rabinowitz, I.
Affiliation
  • Brayer KJ; Department of Internal Medicine / Molecular Medicine, University of New Mexico, Albuquerque, NM.
  • Hanson JA; Department of Pathology, University of New Mexico, Albuquerque, NM.
  • Cingam S; Department of Internal Medicine/ Division of Hematology- Oncology, University of New Mexico, Albuquerque, NM.
  • Martinez C; Department of Pathology, University of New Mexico, Albuquerque, NM.
  • Ness SA; Department of Internal Medicine / Molecular Medicine, University of New Mexico, Albuquerque, NM.
  • Rabinowitz I; Department of Internal Medicine/ Division of Hematology- Oncology, University of New Mexico, Albuquerque, NM.
bioRxiv ; 2023 Mar 29.
Article in En | MEDLINE | ID: mdl-37034706
Pancreatic ductal adenocarcinoma (PDAC) is a poor prognosis cancer with an .aggressive growth profile that is often diagnosed at late stage and that has few curative or therapeutic options. PDAC growth has been linked to alterations in the pancreas microbiome, which could include the presence of the fungus Malassezia. We used RNA-sequencing to compare 14 paired tumor and normal (tumor adjacent) pancreatic cancer samples and found Malassezia RNA in both the PDAC and normal tissues. Although the presence of Malassezia was not correlated with tumor growth, a set of immune- and inflammatory-related genes were up-regulated in the PDAC compared to the normal samples, suggesting that they are involved in tumor progression. Gene set enrichment analysis suggests that activation of the complement cascade pathway and inflammation could be involved in pro PDAC growth.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article